Background Cancer is the second leading cause of death in the United States. 1 With advances in cancer screening and treatment, survival rates have increased by 20% over the past 4 decades. 2 Despite increased survival rates, quality of life
Search Results
Effect of Yoga and Mediational Influence of Fatigue on Walking, Physical Activity, and Quality of Life Among Cancer Survivors
Po-Ju Lin, Brian J. Altman, Nikesha J. Gilmore, Kah Poh Loh, Richard F. Dunne, Javier Bautista, Chunkit Fung, Michelle C. Janelsins, Luke J. Peppone, Marianne K. Melnik, Kim O. Gococo, Michael J. Messino, and Karen M. Mustian
Relationship Between Quality of Life and Survival in Patients With Pancreatic and Periampullary Cancer: A Multicenter Cohort Analysis
Tara M. Mackay, Anouk E.J. Latenstein, Mirjam A.G. Sprangers, Lydia G. van der Geest, Geert-Jan Creemers, Susan van Dieren, Jan-Willem B. de Groot, Bas Groot Koerkamp, Ignace H. de Hingh, Marjolein Y.V. Homs, Evelien J.M. de Jong, I. Quintus Molenaar, Gijs A. Patijn, Lonneke V. van de Poll-Franse, Hjalmar C. van Santvoort, Judith de Vos-Geelen, Johanna W. Wilmink, Casper H. van Eijck, Marc G. Besselink, Hanneke W.M. van Laarhoven, and for the Dutch Pancreatic Cancer Group
Background Patient-reported outcome measures (PROMs) are used increasingly in clinical practice to assess patients’ quality of life (QoL). Addressing QoL is important for patients with a short life expectancy, such as those with pancreatic and
Symptom Burden, Perceived Control, and Quality of Life Among Patients Living With Multiple Myeloma
Alexandra K. Zaleta, Melissa F. Miller, Julie S. Olson, Eva Y.N. Yuen, Thomas W. LeBlanc, Craig E. Cole, Shauna McManus, and Joanne S. Buzaglo
quality of life (QoL), including fatigue, pain, breathlessness, muscle weakness, and peripheral neuropathy, 11 , 12 which can negatively impact work, social, and familial roles. 13 Research has shown patients with MM experience greater symptom burden and
Quality of Life Is Associated With Survival in Patients With Gastric Cancer: Results From the Randomized CRITICS Trial
Romy M. van Amelsfoort, Iris Walraven, Jacobien Kieffer, Edwin P.M. Jansen, Annemieke Cats, Nicole C.T. van Grieken, Elma Meershoek-Klein Kranenbarg, Hein Putter, Johanna W. van Sandick, Karolina Sikorska, Cornelis J.H. van de Velde, Neil K. Aaronson, Marcel Verheij, and on behalf of the CRITICS Investigators
treatment strategies. 8 Assessing health-related quality of life (HRQoL) in clinical trials is increasingly important because it addresses the impact of treatment from the patient’s perspective. Recent studies by Basch et al 9 and Denis et al 10 have
Health-Related Quality of Life in Patients With Metastatic Colorectal Cancer Undergoing Systemic Therapy With or Without Maximal Tumor Debulking
Lotte Bakkerus, Laurien M. Buffart, Tineke E. Buffart, Yannick M. Meyer, Barbara M. Zonderhuis, Cornelis J.A. Haasbeek, Kathelijn S. Versteeg, Olaf J.L. Loosveld, Jan Willem B. de Groot, Mathijs P. Hendriks, Cornelis Verhoef, Hendrik M.W. Verheul, and Elske C. Gootjes
Background Maintaining sufficient health-related quality of life (HRQoL) is an important goal in the treatment of patients with metastatic colorectal cancer (mCRC) as well as for their caregivers, and in the evaluation of new anticancer
Change Toward Healthier Lifestyles Is Associated With Better Health-Related Quality of Life in Long-Term Colorectal Cancer Survivors
Ruth Elisa Eyl-Armbruster, Melissa S.Y. Thong, Prudence R. Carr, Lina Jansen, Jenny Chang-Claude, Michael Hoffmeister, Hermann Brenner, and Volker Arndt
), no change-low (HLS remained ≤2), or decreased (baseline HLS > 5YFU HLS). Health-Related QoL At 5YFU and 10YFU, HRQoL was measured with the EORTC Quality of Life Questionnaire-Core 30, 13 which comprises 5 functional scales, 1 global health
Impact of Patient- and Clinician-Reported Cumulative Toxicity on Quality of Life in Patients With Metastatic Castration-Naïve Prostate Cancer
Claudia S.E.W. Schuurhuizen, Patricia Marino, Annemarie M.J. Braamse, Laurien M. Buffart, Florence Joly, Karim Fizazi, Muriel Habibian, Jean-Marie Boher, Michel Soulie, Stéphane Oudard, Inge R.H.M. Konings, Henk M.W. Verheul, Joost Dekker, and Gwenaelle Gravis
(systemic) treatments may be limited, the number and extent of AEs and their impact on patient quality of life (QoL) are important. 2 Providing a representative overview of treatment-related AEs is essential for patients to make an informed decision to
Advance Care Planning Improves Psychological Symptoms But Not Quality of Life and Preferred End-of-Life Care of Patients With Cancer
Siew Tzuh Tang, Jen-Shi Chen, Fur-Hsing Wen, Wen-Chi Chou, John Wen-Cheng Chang, Chia-Hsun Hsieh, and Chen Hsiu Chen
– 9 but also may facilitate adjustment to the uncertainty inherent in EoL care decision-making, thus alleviating anxiety and depressive symptoms and improving quality of life (QoL). 10 , 11 The few randomized controlled trials (RCTs) of ACP studies
Cancer Rehabilitation: Impact on Breast Cancer Survivors’ Work Ability and Health-Related Quality of Life
Mackenzi Pergolotti, Kelley C. Wood, Tiffany Kendig, Kim Love, and Stacye Mayo
reported by BCSs in acute, long-term, and late-onset phases. 6 , 7 Without intervention, these impairments are likely to worsen over time, 6 , 8 , 9 negatively impacting ability to work 5 , 10 and health-related quality of life (HRQoL), 3 – 5 , 11 and
Evaluation of Scores to Reflect Toxicity Impact on Quality of Life of Patients With Platinum-Resistant Ovarian Cancer: AURELIA Substudy
Justine Lequesne, Florence Joly, Julien Peron, Isabelle Ray-Coquard, Anne-Claire Hardy-Bessard, Frédéric Selle, Dominique Berton, Philippe Follana, Michel Fabbro, Alain Lortholary, Eric Pujade-Lauraine, Sophie Lefèvre-Arbogast, and Elodie Coquan
Background In palliative oncology practice, the benefit/risk balance is iteratively assessed to decide the more beneficial and acceptable treatment for patients. Anticipated effects of treatments on patients’ quality of life (QoL) are highly
